BRCA1 and breast cancer: Although a risk-reducing mastectomy is a highly effective procedure for women with a BRCA1 mutation, the low uptake and high opt-out rate for these women for screening instead underlies the need to develop new, non-invasive preventative agents and strategies for managing BRCA1-associated breast cancer risk.